Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ustekinumab in Adult Japanese Subjects With Severe Atopic Dermatitis
NCT01945086Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Sep 2013
- Primary completion
- Dec 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ustekinumab in atopic dermatitis (AD), sponsored by Janssen Pharmaceutical. Started Sep 2013; status: completed.
02
Drugs
ustekinumab
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT01945086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01945086.